Abstract
Myocardial contractility may change in response to altered circulatory demands imposed by physiological stimuli. Many studies have explored the behavior of cardiac contraction during shock of various etiologies. In the final phase of circulatory shock, clinical signs of circulatory insufficiency are indicated by low peripheral perfusion, low mean arterial blood pressure, high heart rate, and central venous congestion. A point is reached in the progression of the syndrome where fatal cardiovascular collapse occurs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
R. D. Aarons and P.B. Molinoff, Changes in the density of beta-adrenergic receptors in rat lymphocytes, heart, and lung after chronic treatment with propranolol, Pharmacol. Exptl. Ther. 221: 439 (1981).
R. D. Aarons, A. S. Nies, J. G. Gerber, and P. B. Molinoff, Decreased beta-adrenegic receptor density on human lymphocytes after chronic treatment with agonists, J. Pharmacol. Exptl. Ther. 224: 1 (1982).
H. R. Adams, C. R. Baxter, J. L. Parker, and N. B. Watts, Contractile function and rhythmicity of cardiac preparations from E. coli endotoxin-shocked guinea pigs, Circ. Shock 13: 241 (1984).
L. T. Archer, B. A. Benjamin, B. K. Beller-Todd, D. J. Brackett, M. F. Wilson, and L. B. Hinshaw, Does LD coli shock cause myocardial failure? Circ. Shock 9: 7 (1982).
C. R. Benedict and D. G. Grahame-Smith, Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and hemorrhage, Quart. J. Med. 185: 1 (1978).
B. L. Brown, J. D. M. Albano, R. P. Ekins, A. M. Sgherzi, and A. L. Tampion, A simple and sensitive saturation assay method for the measurement of adenosine 3′5′-cyclic monophosphate, Biochem. J. 121: 561 (1971).
W. S. Colucci, R. W. Alexander, G. H. Williams, R. E. Rude, B. L. Holman, M. A. Konstam, J. Wayne, G. H. Mudge, and E. Braunwald, Decreased lymphocyte beta-adrenergic receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist, Pirbuterol. N. Eng. J. Med. 305 (1981).
S. E. Epstein and E. Braunwald, The effect of beta adrenergic blockade on patterns of urinary sodium excretion: studies in normal subjects and in patients with heart disease, Ann. Intern. Med. 65: 20 (1966).
R. D. Feldman, L. E. Limbird, J. Nadeau, D. Robertson, A. J. J. Wood, Leukocyte beta-receptor alterations in hypertensive subjects, J. Clin. Invest. 73: 648 (1984).
R. D. Feldman, L. E. Limbird, J. Nadeau, G. H. Fitzgerald, D. Robertson, and A. J. J. Wood, Dynamic regulation of leukocyte beta-adrenergic receptor-agonist interactions by physiological changes in circulating catecholamines, Clin. Invest. 72: 164 (1983).
R. E. Fish, A. H. Burns, C. H. Lang, and J. A. Spitzer, Myocardial dysfunction in a non-lethal, non-shock model of chronic endotoxemia, Circ. Shock 16 (1985).
T. J. Franklin, W. P. Morris, and P. A. Twose, Densensitization of beta-adrenergic receptors in human fibroblasts in tissue culture, Mol. Pharmacol. 11: 485 (1975).
J. Fraser, J. Nadeau, J. D. Robertson, and A. J. J. Wood, Regulation of human leukocyte beta receptors by endogenous catecholamines. Relationship of leukocyte beta receptor density to the cardiac sensitivity to isoproterenol, Clin. Invest. 67: 1777 (1984).
T. E. Gaffney and E. Braunwald, Importance of the adrenergic nervous system in the support of circulatory function in patients with congestive heart failure, Am. Med. 34: 320 (1963).
R. P. Gilbert, Mechanisms of the hemodynamic effects of endotoxin, Physiol. Rev. 40: 245 (1960).
A. G. Gilman, A protein kinase binding assay for adenosine 3′,5′-cyclic monophosphate, Proc. Natl. Acad. Sci. USA 67: 305 (1970).
R. D. Goldfarb, Cardiac dynamics following shock: role of circulating cardiodepressant substances, Circ. Shock 9: 317 (1982).
R. D. Goldfarb, W. Tambolini, S. M. Wiener, and P. B. Weber, Caninen left ventricular performance during LD endotoxemia, Am. J. Physiol. 244: H370 (1983).
T. K. Harden, Y. F. Su, and J. P. Perkins, Catecholamine-induced desensitization involved in uncoupling beta-adrenergic receptors and adenylate cyclase, J. Cyclic Nucleotide Res. 5: 99 (1979).
D. C. Harrison, Effects of beta-blockade on circulatory dynamics, in: “Beta-Adrenergic Blockade: A New Era in Cardiovascular Medicine,” E. Braunwald, ed., Excerpta Medica, Amsterdam (1978).
M. L. Hess, Subcellular function in the acutely failing myocardium, Circ. Shock 6: 119 (1979).
M. L. Hess and S. M. Krause, Contractile protein dysfunction as a determinant of depressed cardiac contractility during endotoxin shock, J. Mol. Cardiol. 12:715 (1981).
M. L. Hess, A. Hastillo, and L. J. Greenfield, Spectrum of cardiovascular function during gram-negative sepsis, Prog. Cardiovascular Dis. 23: 279 (1981).
L. B. Hinshaw, Role of the heart in the pathogenesis of endotoxin shock: a review of the clinical findings and observations on animal species, J. Surg. Res. 17: 134 (1974).
L. B. Hinshaw, L. T. Archer, J. J. Spitzer, M. R. Black, M. D. Peyson, and L. J. Greenfield, Effects of coronary hypotension and endotoxin on myocardial performance, Am. J. Physiol. 227: 1051 (1974).
L. B. Hinshaw, B. Benjamin, L. T. Archer, and M. D. Payton, The heart and endotoxin shock, Tex. Rep. Biol. Med. 39: 173 (1979).
L. B. Hinshaw, Overview of endotoxin shock, in: “Pathophysiology of Shock, Anoxia and Ischemia,” R. A. Cowley and B. F. Trump, eds., Williams and Wilkins, Baltimore (1982).
P. Hjemdahl, M. Daleskog, and T. Kahan, Determination of plasma catecholamines by high-performance liquid chromatography with electro-chemical detection: Comparison with a radioenzymatic method, Life Sciences 25: 131 (1979).
M. J. Hoffman, L. J. Greenfield, H. J. Sugerman, and J. L. Taturm, Unsuspected right ventricular dysfunction in shock and sepsis, Ann. Surg. 198: 307 (1983).
S. B. Jones and F. D. Romano, Plasma catecholamine in the conscious rat during endotoxicosis, Circ. Shock 14: 189 (1984).
G. L. Johnson, B. B. Wolfe, T. K. Harden, P. B. Molinoff, and J. P. Perkins, Role of beta-adrenergic receptors in catecholamine-induced desensitization of adenylate cyclase in human astrocytoma cells, J Biol. Chem. 253: 1472 (1978).
A. M. Katz, Role of the contractile proteins and sarcoplasmic reticulum in the response of the heart to catecholamine: a historic review, Adv. Cyclic Nucleotide Res. 11: 303 (1979).
R. S. Kent, A. Delean, and R. J. Lefkowitz, A quantitative analysis of beta adrenergic receptor interactions: resolution of high and low affinity states of the receptor by computer modelling of ligand binding data, Mol. Pharmacol 17: 14 (1980).
J. F. Krall, M. Connelly, and M. L. Tuck, Acute regulation of beta adrenergic catecholamine sensitivity in human lymphocytes, J Pharmacol. Exptl. Ther. 214: 554 (1980).
E. Lachman, S. B. Pitsoe, and S. L. Goffin, Anti-lipopolysaccharide immunotherapy in management of septic shock of obstetric and gynaecological origin, Lancet 8384: 981 (1984).
C. H. Lang, G. J. Bagby, and J. J. Spitzer, Glucose kinetics and body temperature after lethal and nonlethal doses of endotoxin, Am. J. Physiol. 248: R000 (1985).
A. M. Lefer and M. J. Rovetto, Influence of myocardial depressant factor on physiologic properties of cardiac muscle, Proc. Soc. Exp. Biol. Med. 134: 269 (1970).
O. H. Lowry, N. J. Rosebrough, A. L. Farr, and R. J. Randall, Protein measurement with the folin phenol reagent, J. Biol. Chem. 193: 265 (1951).
J. McCaig, K. A. Kane, G. Bailey, P. F. Millington, and J. R. Parratt, Myocardial function in feline endotoxin shock: a correlation between myocardial contractility, electrophysiology, and ultrastructure, Circ. Shock 6: 201 (1979).
K. H. McDonough, C. H. Lang, and J. J. Spitzer, Depressed function of isolated hearts from hyperdynamic, septic rats. Circ. Shock 12; 241 (1984).
J. Montini, G. J. Bagby, A. H. Burns, and J. J. Spitzer, Am. J. Physiol. 240: H659 (1981).
J. R. Neely, H. Liebermeister, E. J. Battersby, and H. E. Morgan, Effect of pressure development on oxygen consumption by isolated rat heart, Am. J. Physiol. 212: 804 (1967).
J. L. Parker and H. R. Adams, Myocardial effects of endotoxin shock: characterization of an isolated heart muscle model, Adv. Shock Res. 2: 163 (1979).
J. L. Parker and H. R. Adams, Contractile dysfunction of atrial myocardium from endotoxin-shocked guinea pigs, Am. J. Physiol 240: 11954 (1981).
M. Pollack, A. I. Huang, R. K. Prescott, L. S. Young, K. W. Hunter, D. F. Cruess, and C.-M. Tsai, Enhanced survival in Pseudomonas aeruginosa septicemia associated with high levels of circulating antibody to E. coli endotoxin core, Clin. Invest. 72: 1874 (1983).
J. Postel and P. R. Schloerb, Cardiac depression in bacteremia, Ann. Surg. 186: 74 (1977).
J. Raffa and D. D. Trunkey, Myocardial depression in sepsis, J. Trauma 18: 617 (1978).
E. Remold-O’Donnell, Stimulation and desensitization of macrophage adenylate cyclase by prostaglandins and catecholamines, Biol. Chem. 249: 3615 (1974).
G. A. Robison, R. W. Butcher, I. Oye, H. E. Morgan, and E. W. Sutherland, The effect of epinephrine on adenosine 3′,5′-phosphate levels in isolated perfused rat heart, Mol. Pharmacol. 1: 168 (1965).
A. J. Romanosky, A. H. Burns, and R. E. Shepherd, In vitro myocardial performance following in vivo administration of E. coli endotoxin, Fed. Proc. 42:608 (1983).
E. M. Ross and A. G. Gilman, Biochemical properties of hormone-sensitive adenylate cyclase, Ann. Rev. Biochem. 49: 533 (1980).
G. Scatchard, The attractions of proteins for small molecules and ions, Ann. N.Y Acad. Sci. 51: 660 (1949).
M. Shear, P. Insel, K. L. Melmon, and P. Coffino, Agonist specific refractoriness induced by isoproterenol. Studies with mutant cells, J. Biol. Chem. 251: 7572 (1976).
R. E. Shepherd, K. H. McDonough, and A. H. Burns, Mechanism of cardiac dysfunction in hearts from endotoxin-treated rats, Circ. Shock 13: 95 (1984).
J. H. Siegel, F. B. Cerra, B. Coleman, I. Giocannini, M. Shetye, J. R. Border, and R. H. McMenamy, Physiological and metabolic correlation in human sepsis, Surgery 86: 163 (1979).
J. F. Spann, E. H. Sonneblick, T. Cooper, C. A. Chidsey, V. L. William, and E. Braunwald, Cardiac norepinephrine stores and the contractile state of heart muscle, Circ. Res. 19: 317 (1966).
J. J. Spitzer, Studies of substrate metabolism in isolated myocytes, in: “Myocardial Injury,” J. J. Spitzer, ed., Plenum Publishing Corporation, New York (1983).
G. L. Stiles, M. G. Caron, and R. J. Lefkowitz, Beta-adrenergic receptors: biochemical mechanisms of physiological regulation, Physiol. Rev. 64: 661 (1984).
T. E. Temples, A. H. Bums, F. C. Nance, and H. I. Miller, Effect of burn shock on myocardial function in guinea pigs, Circ. Shock 14: 81 (1984).
C. S. Thomas, M. A, Melly, M. G. Koenig, and S. K. Brockman, The hemodynamic effects of viable gram-negative organisms, Surg. Gynecol. Obstet. 128: 753 (1969).
J. P. Weisul, T. F. O’Donnell, M. A. Stone, and G. H. Clowes, Myocardial performance in clinical septic shock: effects of isoproterenol and glucose potassium insulin, J. Surg, Reg, 18: 357 (1975).
E. J. Winslow, H. S. Loeb, S. Kamath, and R. M. Gunnar, Hemodynamic studies and results of therapy in 50 patients with bacteremic shock, Am. J. Med. 54: 421 (1973).
E. J. Ziegler, J. A. McCutchan, J. Furer, M. P. Glauser, J. C. Scadoff, H. Douglas, and A. I. Braude, Treatment of gram-negative bacteremia and shock with human antiserum to mutant Escherichia coli, N. Eng. J. Med. 307: 1225 (1982).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Plenum Press, New York
About this chapter
Cite this chapter
Shepherd, R.E., Lang, C.H., Brumfield, B.A., Robie, N.W., DuSapin, K.R., McDonough, K.H. (1986). Myocardial Performance and Adrenergic Modulation of Cyclic AMP Following Endotoxin Administration. In: Szentivanyi, A., Friedman, H., Nowotny, A. (eds) Immunobiology and Immunopharmacology of Bacterial Endotoxins. University of South Florida International Biomedical Symposia Series, vol 18. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2253-5_14
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2253-5_14
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9319-4
Online ISBN: 978-1-4613-2253-5
eBook Packages: Springer Book Archive